Pieris Pharmaceuticals Aktie (A12G4Q

Aktuelle Nachrichten zu Pieris Pharmaceuticals

Das berichten andere über Pieris Pharmaceuticals

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

Biogen Inc (NASDAQ:BIIB, XETRA:IDP) will acquire Apellis Pharmaceuticals Inc (NASDAQ:APLS) for $41 per share in cash, in a deal valued at approximately $5.6...

Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage...

Global Medical Foods Market Size To Worth USD 49.73 Billion By 2033 | CAGR Of 7.24%

The Global Medical Foods Market Size Was Valued at USD 24.73 Billion in 2023 and the Worldwide Medical Foods Market Size is Expected to Reach USD 49.73 Billion by 2033, according...